Healthcare Industry News: Biosense Webster
News Release - August 27, 2007
Advanced Medical Optics Hires Richard J. DeRisio as Vice President, Global Regulatory AffairsSANTA ANA, Calif.--(HSMN NewsFeed)--Advanced Medical Optics, Inc. (AMO) (NYSE:EYE ), a global leader in ophthalmic surgical devices and eye care products, today announced the appointment of Richard J. DeRisio to vice president, global regulatory affairs.
DeRisio will oversee development and execution of worldwide regulatory strategies for AMO's new and existing products, which are sold in more than 70 countries.
"We are pleased to welcome aboard Richard, as he brings to AMO more than 25 years of regulatory and professional management experience in the medical device industry," said AMO Executive Vice President, Research and Development Leonard Borrmann. "Richard's knowledge and expertise will help us continue to strengthen our global R&D leadership team and support AMO's growth across its three businesses."
Most recently, DeRisio served as vice president, global regulatory affairs at Kinetic Concepts Incorporated, a high growth medical technology company. He has held similar positions at cutting edge device companies including STERIS Corporation, Computer Motion Incorporated, Johnson & Johnson's Biosense Webster Incorporated, Sorin Biomedical, and Ventritex Incorporated.
DeRisio received a bachelor's degree in chemical engineering and a master's degree in food science & technology from Cornell University.
About Advanced Medical Optics (AMO)
AMO develops advanced, life-improving vision technologies for people of all ages. Products in the cataract/implant line include intraocular lenses (IOLs), phacoemulsification systems, viscoelastics, and related products used in ocular surgery. AMO owns or has the rights to such product brands as ReZoom®, Tecnis®, Clariflex®, Sensar®, and Verisyse® IOLs, Sovereign®, Sovereign® Compact and WhiteStar Signature(TM) phacoemulsification systems with WhiteStar® technology, Healon® viscoelastics, and the Baerveldt® glaucoma shunt. Products in the laser vision correction line include wavefront diagnostic devices, femtosecond lasers and associated patient interface devices, and excimer laser vision correction systems and treatment cards. AMO brands in the laser vision correction business include Star S4 IR®, WaveScan Wavefront®, Advanced CustomVue(TM), IntraLase® FS, IntraLase Method(TM) and IntraLasik®. Products in the contact lens care line include disinfecting solutions, enzymatic cleaners and lens rewetting drops. Among the eye care product brands the company possesses are COMPLETE®, COMPLETE® Blink-N-Clean®, Consept®F, Consept® 1 Step, Oxysept® 1 Step, UltraCare®, Ultrazyme®, Total Care(TM) and blink(TM) branded products. AMO is based in Santa Ana, California, and employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company's Website at www.amo-inc.com.
Source: Advanced Medical Optics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.